In a press release issued on August 1, 2017, The European Medicines Agency (EMA) announced that it “has developed and initiated a business continuity plan to deal with the uncertainty and workload implications linked to the United Kingdom's (UK's) withdrawal from the European Union (EU) and the Agency's...
Thursday, August 3, 2017 | Read More
Sentry BioPharma Services provides drug product management, global drug distribution, GMP storage and specialized services like pharmaceutical labeling, packaging and kitting. Sentry plays a critical role in protecting temperature-sensitive product safety, identity, strength, purity and quality (SISPQ)...
Monday, July 31, 2017 | Read More
JULY 6, 2017 INDIANAPOLIS, IN Sentry BioPharma Services recently hosted a round table discussion with Congressman Trey Hollingsworth (IN 9th District) and representatives of BIO and the Indiana Health Industry Forum (IHIF). BIO organized the event as a part of its “535 Congressional Initiative 2017”. BIO...
Wednesday, July 12, 2017 | Read More
Sophisticated physical and data security measures protect valuable information, pharmaceutical materials, and products while in Sentry's possession. Sentry deploys a robust security program based on industry best practices, market trends, agency intelligence and audit feedback. Sentry maintains steadfast control over product classifications and locations, with segregation capabilities for labeling, returns, quarantine, and controlled substances as well as enhanced security and anti-counterfeiting measures for high-value products. Security measures inside and outside the facility protect, monitor and control access.
Sentry's Pharmaceutical Supply Chain Security: